Caribou Biosciences, Inc.

Nasdaq CRBU · Berkeley, CA

Works in Cardiovascular · Dermatology · Hematology · Immunology · Oncology · Renal & urogenital · Women's health

Caribou Biosciences, Inc. is a clinical trial sponsor based in Berkeley, CA, listed as Nasdaq CRBU. It has 3 active clinical trials with 272 planned participants, across 7 therapeutic areas. Since 2021 it has completed 0 trials and stopped 2 early.

Trial track record · since 2021

3Active trials272 planned participants
0Completed0 with results posted
2Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq CRBU

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 3 active trials

StageTrialStatus

Questions about Caribou Biosciences, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-19.

Approve Suite is not affiliated with Caribou Biosciences, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.